Clinical Trials Logo

Clinical Trial Summary

Selective cannulation of common bile duct (CBD) by insertion of a guide-wire seems to be associated with fewer complications and post-ERCP (Endoscopic retrograde cholangiopancreatography) pancreatitis (PEP) rate than the conventional biliary tree access with cannulotome (CT-25 Cook Medical) with contrast injection even if results are conflicting. the aim of our study is to test a new guide-wire (loop-tip wire), with a loop in the tip, for the prevention of PEP and biliary tree access, in PEP high-risk patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01771419
Study type Interventional
Source Hospital San Paolo
Contact
Status Unknown status
Phase N/A
Start date October 2010
Completion date January 2014

See also
  Status Clinical Trial Phase
Completed NCT02476279 - Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis Phase 3
Completed NCT04876768 - Effects of High FIO2 on Post-ERCP Pancreatitis. N/A
Not yet recruiting NCT06250803 - Early Pancreatic Stent Placement for Preventing PEP N/A
Completed NCT01912716 - Rectal Indomethacin in the Prevention of Post-ERCP Pancreatitis Phase 2/Phase 3
Terminated NCT00820612 - Rectal Indomethacin in the Prevention of Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis in High Risk Patients Phase 4
Recruiting NCT04750044 - Refeeding in Post-ERCP Pancreatitis N/A
Completed NCT03643900 - The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis N/A
Terminated NCT03749590 - Magnesium Sulfate in the Prevention of Post-ERCP Pancreatitis. Phase 3
Recruiting NCT03708458 - Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis Phase 4